Skip to main content
SpringerLink
Log in

Poor Sleep and Daytime Somnolence in Allergic Rhinitis

Significance of Nasal Congestion

  • Leading Article
  • Published:
American Journal of Respiratory Medicine

Abstract

Patients with allergic rhinitis frequently present with symptoms of nasal congestion, runny nose, sneezing, daytime somnolence and fatigue associated with decreased cognitive performance and impaired quality of life. Recent research has suggested that daytime somnolence in allergic rhinitis can be attributed to chronic inflammation of the nasal mucosa leading to nasal congestion and obstructed nasal passageways resulting in disturbed sleep.

Treating daytime somnolence due to allergic rhinitis requires a reduction in obstruction caused by nasal congestion. Currently available therapy for allergic rhinitis includes topical corticosteroids, sedating and non-sedating antihistamines, topical cromolyn sodium (sodium cromoglycate), decongestants, immunotherapy and topical ipratropium bromide.

The effectiveness of antihistamines in patients with allergic rhinitis has long been established. However, results of placebo-controlled trials investigating the effects of azelastine on sleep and daytime somnolence have produced conflicting results. Sleep improved with azelastine therapy, but there was a lack of evidence that azelastine significantly affected daytime sleepiness, sleep severity and nasal congestion. Sedating antihistamines exacerbate daytime somnolence and should be avoided in patients with allergic rhinitis. In a separate study, desloratadine failed to benefit sleep, but did not worsen daytime somnolence.

Topical nasal cromolyn sodium is inconvenient to use and is unlikely to have a major effect on nasal congestion. Decongestants do decrease nasal congestion but the effect this has on sleep has not been adequately studied.

Recent research has shown that topical corticosteroids are an effective treatment for alleviating nasal congestion secondary to allergic rhinitis. However, few studies have assessed the effect of topical corticosteroids on daytime fatigue and sleep. In 20 patients with allergic rhinitis and symptoms of daytime sleepiness, flunisolide significantly improved sleep quality and congestion but daytime sleepiness was not significantly improved. A similar study with fluticasone propionate showed improvement in nasal congestion and sleep but there was no significant change in objective sleep measurements recorded on polysomnography.

Further research involving objective measures of sleep quality is necessary to determine the efficacy of medications in the treatment of allergic rhinitis associated with fatigue and daytime somnolence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Kay AB, Mackay IR, Rosen FS. Allergy and allergic diseases. N Engl J Med 2001; 344: 30–7

    Article  PubMed  CAS  Google Scholar 

  2. Baraniuk J. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 1997; 99: S763–72

    Article  PubMed  CAS  Google Scholar 

  3. Fajac I, Braunstein G, Ickovic MR, et al. Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis. Allergy 1995; 50: 970–5

    Article  PubMed  CAS  Google Scholar 

  4. Okamoto Y, Shirotori K, Kudo K, et al. Cytokine expression after topical administration of substance P to human nasal mucosa: the role of substance P to human nasal allergy. J Immunol 1993; 151(8): 4391–8

    PubMed  CAS  Google Scholar 

  5. Morrison DL, Launois SH, Isono S, et al. Pharyngeal narrowing and closing pressures in patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 148: 606–11

    Article  PubMed  CAS  Google Scholar 

  6. Zwillich C, Pickett C, Hanson F, et al. Disturbed sleep and prolonged apneas during nasal obstruction in normal men. Am Rev Respir Dis 1981; 124: 159–60

    Google Scholar 

  7. Olsen KD, Suh KW, Staats BA. Surgically correctable causes of sleep apnea syndrome. Otolaryngol Head Neck Surg 1981; 89: 726–31

    PubMed  CAS  Google Scholar 

  8. Suratt PM, Turner BL, Wilhoit SC. Effect of nasal obstruction on breathing during sleep. Chest 1986; 90(3): 324–9

    Article  PubMed  CAS  Google Scholar 

  9. Young T, Finn LMS, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. J Allergy Clin Immunol 1997; 99: S757–62

    Article  PubMed  CAS  Google Scholar 

  10. Shepard JW, Burger CD. Nasal and oral flow-volume loops in normal subjects and patients with obstructive sleep apnea. Am Rev Respir Dis 1990; 142: 1288–93

    PubMed  Google Scholar 

  11. Lavie P, Gertner R, Zomer J, et al. Breathing disorders in sleep associated with ‘microarousals’ in patients with allergic rhinitis. Acta Otorhinolaryngol 1981; 92: 529–33

    Article  CAS  Google Scholar 

  12. McNicholas WT, Tarlo S, Cole P, et al. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 1982; 126: 625–8

    PubMed  CAS  Google Scholar 

  13. Rubinstein I. Nasal inflammation in patients with obstructive sleep apnea. Laryngoscope 1995; 105: 175–7

    Article  PubMed  CAS  Google Scholar 

  14. White DP, Cadieux RJ, Lombard RM, et al. The effects of nasal anesthesia on breathing during sleep. Am Rev Respir Dis 1985; 132: 972–5

    PubMed  CAS  Google Scholar 

  15. Leznoff A, Haight JS, Hoffstein V. Reversible obstructive sleep apnea caused by occupational exposure to guar gum dust. Am Rev Respir Dis 1986; 133: 935–6

    PubMed  CAS  Google Scholar 

  16. Mossiman BL, White MV, Hohman RJ, et al. Substance P, calcitonin-gene related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol 1993; 92: 95–104

    Article  Google Scholar 

  17. McColley SA, Carroll JL, Curtis S, et al. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 1997; 111: 170–3

    Article  PubMed  CAS  Google Scholar 

  18. Vuurman EFPM, van Veggel LMA, Uiterwijk MMC, et al. Seasonal allergic rhinitis and antihistamine effects on children’s learning. Ann Allergy 1993; 71: 121–6

    PubMed  CAS  Google Scholar 

  19. Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: a randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med 2000 Mar 7; 132(5): 354–63

    PubMed  CAS  Google Scholar 

  20. Juniper E. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 1997; 99: S742–9

    Article  PubMed  CAS  Google Scholar 

  21. Flemons WW, Tsai W. Quality of life consequences on sleep-disordered breathing. J Allergy Clin Immunol 1997; 99: S750–6

    Article  PubMed  CAS  Google Scholar 

  22. Martin SE, Engleman MH, Deary IJ, et al. The effect of sleep fragmentation on daytime function. Am J Respir Crit Care Med 1996; 153: 1328–32

    PubMed  CAS  Google Scholar 

  23. Stepanski E, Lamphere J, Badia P, et al. Sleep fragmentation and daytime sleepiness. Sleep 1984; 7: 18–26

    PubMed  CAS  Google Scholar 

  24. Bonnet MH. Infrequent periodic sleep disruption; effects on sleep, performance and mood. Physiol Behav 1989; 45: 1049–55

    Article  PubMed  CAS  Google Scholar 

  25. George CF, Nickerson P, Hanly P, et al. Sleep apnea patients have more automobile accidents. Lancet 1987; I: 477

    Google Scholar 

  26. Findley LJ, Unverzagt ME, Suratt PM. Automobile accidents involving patients with obstructive sleep apnea. Am Rev Respir Dis 1988; 138: 337–40

    PubMed  CAS  Google Scholar 

  27. Sienra-Monge JJ, Gazca-Aguilar A, Del Rio-Navarro B. Double-blind comparison of cetirizine and loratadine in children ages 2 to 6 years with perennial allergic rhinitis. Am J Ther 1999 May; 6(3): 149–55

    Article  PubMed  CAS  Google Scholar 

  28. Golden AS, Teets SJ, Lehman E, et al. Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Ann Allergy Asthma Immunol 2000; 85: 1–5

    Article  Google Scholar 

  29. Ratner PH, Findlay SR, Hampel Jr F, et al. A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis. J Allergy Clin Immunol 1994; 94(5): 818–25

    Article  PubMed  CAS  Google Scholar 

  30. Jordana G, Dolovich J, Briscoe MP, et al. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97: 588–95

    Article  PubMed  CAS  Google Scholar 

  31. Hughs K, Craig T, Mende K, et al. The effect of desloratadine on sleep and daytime somnolence in subjects with allergic rhinitis [abstract]. Am J Respir Crit Care Med 2001; 163: A192

    Google Scholar 

  32. Graft DF. New therapies for allergic rhinitis. Cleve Clin J Med 2000 Mar; 67(3): 165–8

    PubMed  CAS  Google Scholar 

  33. Hendeles L. Selecting a decongestant. Pharmacotherapy 1993; 13 (6 Pt 2): 129S–34S

    PubMed  CAS  Google Scholar 

  34. Orgel HA, Meltzer EO, Kemp JP, et al. Clinical, rhinomanometric, and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray or pressurized aerosol. J Allergy Clin Immunol 1986; 77: 858–64

    Article  PubMed  CAS  Google Scholar 

  35. McAllen MK, Portillo PR, Parr EJ, et al. Intranasal flunisolide, placebo and beclomethasone dipropionate in perennial rhinitis. Br J Dis Chest 1980; 74: 32–6

    Article  PubMed  CAS  Google Scholar 

  36. Storms W, Bronsky E, Findlay S, et al. Once daily triamcinolone acetonide nasal spray is effective for treatment of perennial allergic rhinitis. Ann Allergy 1991; 66: 329–34

    PubMed  CAS  Google Scholar 

  37. Ratner PH, Paull BR, Findlay SR, et al. Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily. J Allergy Clin Immunol 1992; 90: 285–91

    Article  PubMed  CAS  Google Scholar 

  38. Bronsky EA, Dockhorn RJ, Meltzer EO, et al. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97: 915–21

    Article  PubMed  CAS  Google Scholar 

  39. Meltzer EO, Orgel HA, Bronsky EA, et al. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry and nasal cytology. J Allergy Clin Immunol 1990; 86: 221–30

    Article  PubMed  CAS  Google Scholar 

  40. van As A, Bronsky E, Grossman J, et al. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy 1991; 67: 156–62

    PubMed  Google Scholar 

  41. Welch MJ. Topical nasal steroids for allergic rhinitis. West J Med 1993; 158: 616–7

    PubMed  CAS  Google Scholar 

  42. Craig T, Teets S, Lehman E, et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 1998; 101: 633–7

    Article  PubMed  CAS  Google Scholar 

  43. Craig T, Mende C, Hughs K, et al. The effects of nasal fluticasone on objective sleep testing, sleep quality, and daytime somnolence in perennial allergic rhinitis [abstract]. Am J Respir Crit Care Med 2001; 163: A192

    Google Scholar 

Download references

Acknowledgements

Funded by the General Clinical Research Center, Penn State University, Hershey Medical Center, which is supported by the National Institutes of Health (NIH).

Author information

Authors and Affiliations

  1. Department of Medicine, Pulmonary, Allergy, Critical Care, 500 University Drive, Hershey, Pennsylvania, 17033, USA

    Sujani Kakumanu, Casey Glass &  Timothy Craig

Authors
  1. Sujani Kakumanu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Casey Glass
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy Craig
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy Craig.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kakumanu, S., Glass, C. & Craig, T. Poor Sleep and Daytime Somnolence in Allergic Rhinitis. Am J Respir Med 1, 195–200 (2002). https://doi.org/10.1007/BF03256609

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256609

Keywords

Search

Navigation